Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches

Aug.26
Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Group, Ltd. files federal lawsuit against Altria Group for alleged theft of trade secrets in packaging "On!" nicotine pouches.

Key Points: 

 

Plaintiff: UK-based Gumipod Group, Ltd.

Defendants: Altria Group, Inc. and three subsidiaries — Altria Client Services LLC, Helix Innovations LLC (believed to be the owner of the “On!” brand), and Altria Group Distribution Company.

Dispute Origin: After the signing of a confidentiality agreement in 2018, Gumipod provided samples and specifications; Altria announced the collaboration was on hold, but in 2019 launched “On!” nicotine pouches.

Core Allegations: Violations of the Defend Trade Secrets Act (DTSA), violations of the Virginia Uniform Trade Secrets Act (VUTSA), breach of contract, unjust enrichment, and business conspiracy.

Claims: Cease infringement, compensate for losses and punitive damages, pay legal fees, and obtain a permanent injunction.

 


 

On August 22, 2025, according to documents released by the Eastern District Federal Court of Texas in the United States, Gumipod Group, Ltd., based in London, filed a federal lawsuit against tobacco company Altria Group (Altria Group, Inc.) and several of its subsidiaries. The lawsuit accuses Altria of misappropriating its trade secrets for use in the packaging of its popular “On!” brand nicotine pouch products.

 

The defendants named in the complaint include Altria Group itself, along with its three subsidiaries: Altria Client Services LLC, Helix Innovations LLC (alleged to own the “On!” brand), and Altria Group Distribution Company.

 

According to the filing, Gumipod was founded by Duval Middleton in 2011 and developed an innovative “plastic capsule-style gum container” with a built-in recycling bin, allowing consumers to conveniently dispose of chewed gum.

 

In August 2018, Emily Ornelas, then a procurement analyst for Altria, contacted Middleton through Gumipod’s website. Shortly afterward, Kwazna Downs, then Altria’s purchasing manager, reached out via Facebook, clarifying that Altria’s interest was in applying the technology to “nicotine products derived from oral tobacco,” rather than gum.

 

To advance discussions, the parties signed a Mutual Confidentiality Agreement (MCA). A key clause stipulated that the obligation to protect trade secrets would remain in effect “as long as trade secret protection is still available.” Following this, Gumipod provided Altria with 10 product samples and detailed production specifications. However, in October 2018, Altria abruptly notified Gumipod that the project was “on hold.”

 

Less than a year later, in June 2019, Altria publicly acquired and relaunched the “On!” nicotine pouch brand. Gumipod alleges that it did not discover the misappropriation until August 24, 2022, when former Gumipod employee Julian Hogan forwarded Altria’s internal marketing documents related to “On!” to Middleton. Gumipod claims that these documents demonstrated the use of its proprietary packaging technology in the design and marketing of On! products.

 

From a legal perspective, Gumipod has filed five causes of action: violation of the Defend Trade Secrets Act (DTSA), violation of the Virginia Uniform Trade Secrets Act (VUTSA), breach of contract, unjust enrichment, and violation of the Virginia Business Conspiracy Act.

 

The plaintiff is requesting a jury trial and is seeking court orders requiring Altria and its subsidiaries to:

 

Immediately cease the use and sale of products alleged to infringe Gumipod’s intellectual property;

Compensate Gumipod for actual losses and punitive damages (amount to be determined at trial);

Pay legal fees and court costs;

Grant a permanent injunction prohibiting further use of Gumipod’s trade secrets and technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
  Special Report|UK’s Disposable Vape Ban: Compliance Products on the Rise, Yet Loopholes and Weak Enforcement Raise Concerns
Special Report|UK’s Disposable Vape Ban: Compliance Products on the Rise, Yet Loopholes and Weak Enforcement Raise Concerns
On 1 June 2025, the UK officially implemented a ban on disposable e-cigarettes. However, within just two months, the market was flooded with a large number of "replica reusable e-cigarettes," and many consumers continued to use them in a "disposable" manner. After the ban was implemented, did the UK e-cigarette market undergo a compliant restructuring, or did it descend into another form of chaos?
Aug.25
Smoore International Falls Over 6% Again; H1 Net Profit Down Nearly 28%, Short-Term Profitability Pressured by Higher R&D Spending
Smoore International Falls Over 6% Again; H1 Net Profit Down Nearly 28%, Short-Term Profitability Pressured by Higher R&D Spending
Smoore International (06969) continued to decline after its earnings release, falling more than 6% in early trading today. As of press time, the stock was down 5.08% at HK$19.23, with a turnover of HK$466 million.
Aug.28 by 2FIRSTS.ai
BAT CFO Transition: Soraya Benchikh Steps Down, Digital & Information Director Javed Iqbal to Serve as Interim Successor
BAT CFO Transition: Soraya Benchikh Steps Down, Digital & Information Director Javed Iqbal to Serve as Interim Successor
British American Tobacco (BAT) announced that its current Chief Financial Officer (CFO) and Board member, Soraya Benchikh, will step down from her role effective August 26, 2025, and will continue to support the transition until December 31, 2025. The company has initiated the selection process for a permanent successor. In the meantime, current Digital & Information Director Javed Iqbal will serve as Interim CFO.
Aug.27 by 2FIRSTS.ai
Dutch doctors accuse Snapchat of not implementing its ban commitment, with e-cigarette transactions still rampant
Dutch doctors accuse Snapchat of not implementing its ban commitment, with e-cigarette transactions still rampant
In June 2025, the instant messaging app Snapchat promised to take measures to prevent minors from being exposed to illegal e-cigarette transactions through the platform. However, an investigation by doctors from the Leiden University Medical Center in the Netherlands found that the number of e-cigarette sellers not only failed to decrease after the promise but actually increased from 607 to 615. Purchasing remains just as easy.
Aug.28 by 2FIRSTS.ai
Al Fakher Partners with Cannabis Brand Cookies to Launch New Hookah Line Featuring Five Flavors, Including Blueberry Caviar
Al Fakher Partners with Cannabis Brand Cookies to Launch New Hookah Line Featuring Five Flavors, Including Blueberry Caviar
Hookah brand Al Fakher has teamed up with international lifestyle brand Cookies to release a co-branded hookah flavor series, marking Cookies’ first entry into the hookah industry. The collaboration introduces five innovative flavors and officially launched on June 25, 2025, through select retail and online channels.
Aug.18 by 2FIRSTS.ai